STOCK TITAN

Insider plans 5,000-share MRK (NYSE: MRK) sale after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider of the issuer has filed a Form 144 notice to sell 5,000 shares of common stock. The planned sale, through Morgan Stanley Smith Barney LLC on the NYSE, has an aggregate market value of $609,525.00 and an approximate sale date of February 6, 2026.

The 5,000 shares were acquired on February 6, 2026 by exercising options under a registered plan, paid for in cash. The filing notes that 2,482,022,536 shares of the issuer’s common stock were outstanding, providing context for the size of the planned sale.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Merck & Co

NYSE:MRK

MRK Rankings

MRK Latest News

MRK Latest SEC Filings

MRK Stock Data

297.22B
2.48B
0.07%
80.59%
0.95%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
RAHWAY